News Image

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNSĀ®) Device

Provided By GlobeNewswire

Last update: Jun 16, 2025

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161-

-This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19,160-

Read more at globenewswire.com

HELIUS MEDICAL TECHNOLOGIE-A

NASDAQ:HSDT (9/2/2025, 8:08:55 PM)

After market: 6.16 +0.07 (+1.15%)

6.09

-0.03 (-0.49%)



Find more stocks in the Stock Screener

Follow ChartMill for more